|
(1 of 2) Florida Minority Cancer Research & Training Center: Feasibility Studies
|
5P20CA192990-04
|
$165,747
|
REAMS, ROMONIA
|
FLORIDA AGRICULTURAL AND MECHANICAL UNIV
|
|
(2/2) CDU/UCLA Cancer Center Partnership to Eliminate Cancer Health Disparities
|
5U54CA143930-08
|
$704,474
|
FARIAS-EISNER, ROBIN
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
|
(PQ11) Reversing exosome-mediated immune suppression - a novel strategy for cancer therapy
|
5R21CA205644-02
|
$202,439
|
WHITESIDE, THERESA
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
|
(PQ3) The role of damaged DNA in inter-individual variation of tumor immunity
|
5R01CA208756-02
|
$518,165
|
HACOHEN, NIR
|
BROAD INSTITUTE, INC.
|
|
(PQ5) Mitochondria in Leukemic Stem Cell Disease Progression
|
5R01CA205975-02
|
$386,619
|
GHAFFARI, SAGHI
|
ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI
|
|
(PQ8) Genetically faithful murine models for studying disease progression in chronic lymphocytic leukemia
|
1R01CA216273-01
|
$701,924
|
WU, CATHERINE
|
DANA-FARBER CANCER INST
|
|
(PQB-4) Opposing Effects of the SASP in Cancer Progression
|
5R01CA184572-04
|
$329,925
|
HERBIG, UTZ
|
RBHS-NEW JERSEY MEDICAL SCHOOL
|
|
(PQB3) CD4 T cell response to BCR-ABL-positive Leukemia
|
5R01CA185062-04
|
$312,304
|
FARRAR, MICHAEL
|
UNIVERSITY OF MINNESOTA
|
|
(PQB5) Reconstruction of Evolutionary Networks using Cross-Sectional Genomic Data
|
5R01CA185486-04
|
$517,690
|
RABADAN, RAUL
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
(PQC-5) Zwitterionic NIR/Zr-89 Agents for Prostate Cancer Staging and Treatment
|
5R01CA185457-04
|
$640,378
|
FRANGIONI, JOHN
|
CURADEL, LLC
|
|
(PQC2) Localization as a determinant of cancer dormancy
|
5R01CA194596-03
|
$553,740
|
LIN, CHARLES
|
MASSACHUSETTS GENERAL HOSPITAL
|
|
(PQC4) Habitats in Prostate Cancer
|
5R01CA190105-04
|
$681,586
|
GILLIES, ROBERT
|
H. LEE MOFFITT CANCER CTR & RES INST
|
|
(PQD1) lmpact of cytotoxic and targeted therapy on clonal evolution of CLL
|
5R01CA184922-04
|
$553,684
|
WU, CATHERINE
|
DANA-FARBER CANCER INST
|
|
0021.0001 CG 425 METAVIVOR
|
261200800001E
|
$319,219,481
|
UNKNOWN, UNKNOWN
|
LEIDOS BIOMEDICAL RESEARCH, INC.
|
|
0021.0001 CG 425 METAVIVOR
|
261200800001E
|
$319,219,481
|
UNKNOWN, UNKNOWN
|
LEIDOS BIOMEDICAL RESEARCH, INC.
|
|
0021.0001 CG 425 METAVIVOR
|
261200800001E
|
$319,219,481
|
UNKNOWN, UNKNOWN
|
LEIDOS BIOMEDICAL RESEARCH, INC.
|
|
0021.0001 CG 425 METAVIVOR
|
261200800001E
|
$319,219,481
|
UNKNOWN, UNKNOWN
|
LEIDOS BIOMEDICAL RESEARCH, INC.
|
|
1/2 NCCU-DUKE Cancer Disparities Translational Research Partnership
|
5P20CA202924-02
|
$229,982
|
WILLIAMS, KEVIN
|
NORTH CAROLINA CENTRAL UNIVERSITY
|
|
1/2 SDSU/UCSD Cancer Center Comprehensive Partnership
|
5U54CA132379-08
|
$1,258,708
|
MARTINEZ, MARIA
|
UNIVERSITY OF CALIFORNIA SAN DIEGO
|
|
1/2 The Alabama State University/UAB Comprehensive Cancer Center Partnership
|
5P20CA192973-04
|
$191,836
|
MANNE, UPENDER
|
UNIVERSITY OF ALABAMA AT BIRMINGHAM
|
|
1/2 U-HAND (University of Houston/MD Anderson) Program to Reduce Cancer Disparities
|
1P20CA221697-01
|
$324,559
|
REITZEL, LORRAINE
|
UNIVERSITY OF HOUSTON
|
|
2/2 Florida Minority Cancer Research & Training Center: Feasibility Studies
|
5P20CA192992-04
|
$158,966
|
ODEDINA, FOLAKEMI
|
UNIVERSITY OF FLORIDA
|
|
2/2 NCCU-DUKE Cancer Disparities Translational Research Partnership
|
5P20CA202925-02
|
$255,626
|
PATIERNO, STEVEN
|
DUKE UNIVERSITY
|
|
2/2 NCCU-LCCC Partnership in Cancer Research
|
5U54CA156733-08
|
$919,471
|
EARP, HENRY
|
UNIV OF NORTH CAROLINA CHAPEL HILL
|
|
2/2 Ponce School of Medicine-Moffitt Cancer Center Partnership
|
2U54CA163068-06
|
$1,656,304
|
MUNOZ-ANTONIA, TERESITA
|
H. LEE MOFFITT CANCER CTR & RES INST
|
|
2/2 The Alabama State University/UAB Comprehensive Cancer Center Partnership
|
5P20CA192976-04
|
$144,556
|
MISHRA, MANOJ
|
ALABAMA STATE UNIVERSITY
|
|
2/2 U-HAND (University of Houston/MD Anderson) Program to Reduce Cancer Disparities
|
1P20CA221696-01
|
$221,442
|
MCNEILL, LORNA
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
|
2/3 Morehouse Sch of Medicine/Tuskegee Univ/University of Alabama Ca Ctr Partnership
|
5U54CA118623-12
|
$407,680
|
TROY, ROBERTA
|
TUSKEGEE UNIVERSITY
|
|
3/3 Morehouse Sch of Medicine/Tuskegee Univ/University of Alabama Ca Ctr Partnership
|
5U54CA118948-12
|
$1,170,535
|
MANNE, UPENDER
|
UNIVERSITY OF ALABAMA AT BIRMINGHAM
|
|
402 -- A PHASE I TRIAL OF THE SAFETY IMMUNOGENICITY OF RG1-VLP... (PROTOCOL UWI2016-08-02). CONTRACTOR: UNIVERSITY OF WISCONSIN. CONTRACT NO: HHSN261201200033I, TASK ORDER: HHSN261000012. FROM 9/1
|
261201200033I
|
$1,485,915
|
UNKNOWN, UNKNOWN
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
402 -- CHEMOPREVENTION OF COLORECTAL CANCER . CONTRACTOR: UNIVERSITY OF OKLAHOMA, HEALTH SCIENCES CENTER, DUNS: 878648294. CONTRACT NO: HHSN261500038I, TASK ORDER HHSN26100011. FROM 9/15/17 TO 9/14/
|
261201500038I
|
$1,236,052
|
UNKNOWN, UNKNOWN
|
UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR
|
|
5-hydroxymethylcytosine in human cancer
|
5R01CA160965-06
|
$394,250
|
PFEIFER, GERD
|
VAN ANDEL RESEARCH INSTITUTE
|
|
A blood test to identify prostate cancer patients at risk for visceral metastasis
|
1R01CA218356-01
|
$620,500
|
POSADAS, EDWIN
|
CEDARS-SINAI MEDICAL CENTER
|
|
A cohort study among workers exposed to benzene in China
|
ZIA CP010120-02060
|
$169,821
|
Rothman, Nat
|
DCEG (NCI)
|
|
A CROSS-SECTIONAL STUDY OF OCCUPATIONAL EXPOSURE TO TRICHLOROETHYLENE, CHROMOS
|
ZIA CP010121-10363
|
$11,686
|
Lan, Qing
|
DCEG (NCI)
|
|
A highly specific NIRF/PET probe for the detection of cancer and metastases
|
1R43CA210854-01A1
|
$224,958
|
Yang, Xinlin
|
IMOL RADIOPHARMACEUTICALS, LLC
|
|
A Label-Free, Point-of-Care Platform to Diagnose Acute Promyelocytic Leukemia
|
5R01CA190843-03
|
$311,458
|
SOHN, LYDIA
|
UNIVERSITY OF CALIFORNIA BERKELEY
|
|
A Mitogen-induced G Protein-coupled Receptor
|
ZIA SC 009389
|
$151,467
|
Kelly Siebenlist, Kathleen
|
CCR (NCI)
|
|
A Mouse Model of DNMT3A-Associated Hematologic Malignancy
|
5R01CA183252-04
|
$533,845
|
GOODELL, MARGARET
|
BAYLOR COLLEGE OF MEDICINE
|
|
A novel NKG2D-specific BiTE cancer immunotherapy
|
5R01CA164178-05
|
$336,150
|
SENTMAN, CHARLES
|
DARTMOUTH COLLEGE
|
|
A Novel Oncogenic Role for Cdc20 Implications in Adult T Cell Leukemia Treatment
|
5R00CA183914-04
|
$254,171
|
WAN, LIXIN
|
H. LEE MOFFITT CANCER CTR & RES INST
|
|
A Novel Positron Emission Tomography Strategy for Early Detection and Treatment Monitoring of Graft-versus-host Disease
|
5R01CA201719-02
|
$361,504
|
GAMBHIR, SANJIV
|
STANFORD UNIVERSITY
|
|
A novel preclinical model of spontaneous metastasis
|
ZIA BC 011167
|
$524,680
|
Merlino, Glenn
|
CCR (NCI)
|
|
A NOVEL SMALL MOLECULE CX3CR1 ANTAGONIST HALTS METASTASIS
|
2R44CA183362-02A1
|
$822,075
|
SALVINO, JOSEPH
|
ALLIANCE DISCOVERY, INC.
|
|
A phase IIA trial for the safety and tolerability of CD24Fc in prophylaxis of graft vs host disease.
|
1R44CA221513-01
|
$1,017,478
|
DEVENPORT, MARTIN
|
ONCOIMMUNE, INC.
|
|
A rapid spontaneous murine model of CN-AML
|
3R01CA196658-02S1
|
$234,525
|
GRIMES, H.
|
CINCINNATI CHILDRENS HOSP MED CTR
|
|
A rapid spontaneous murine model of CN-AML
|
5R01CA196658-02
|
$575,500
|
GRIMES, H.
|
CINCINNATI CHILDRENS HOSP MED CTR
|
|
A Role for KSHV in the Pathogenesis of Malignancies
|
ZIA SC 010356
|
$317,262
|
Tosato, Giovanna
|
CCR (NCI)
|
|
A Stepped-Care Telehealth Approach to Treat Distress in Rural Cancer Survivors
|
5R21CA198237-02
|
$88,993
|
DANHAUER, SUZANNE
|
WAKE FOREST UNIVERSITY HEALTH SCIENCES
|
|
A Target-Directed Reagent Pipeline via Microfluidic mRNA Display
|
1R21CA204708-01A1
|
$227,675
|
MALMSTADT, NOAH
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
Relevant funding data is only available when one cancer type or one research topic is selected.
|